The federal government will overhaul the clinical trials process in Australia after accepting recommendations of the long awaited Clinical Trials Action Group report. [ + ]

The licensing system for creating stem cells is preventing potentially life saving research and should be streamlined, say Australian stem cell researchers. [ + ]

Hach Company has acquired Accurate Detection and Accurate Measurement.

Australian patent issued for Imm-255, which is an orally administered anti-influenza candidate. [ + ]

Scientists have solved the mystery of the main structural component of elastin and the discovery could lead to major advances in the treatment of burns victims, among others.

The Australian Synchrotron has announced four new senior appointments, including Professor Keith Nugent as Director, and a reorganisation of senior responsibilities.

Vanessa Hayes, now posted at the J Craig Venter Institute (JCVI), conducted a pioneering study of human genetic diversity in the Bushman of the Kalahari desert in Africa. [ + ]

The $94 million La Trobe Institute of Molecular Science began construction last week and is set to open in 2012. [ + ]

Vanessa Hayes is exploring the breadth of human genetic diversity, and revealing some fascinating insights about what makes us who we are. [ + ]

Scientists have developed an atom laser that behaves exactly like a light laser.

Western Australian philanthropist Charles Morgan has offered $20,000 to the team that first publishes a paper using genomics equipment he donated to the state's researchers. [ + ]

Researchers in Western Australia have been offered a prize for the first published research paper to use new gene sequencing equipment.

Professor Emma Whitelaw received the prestigious Jubilee Medal from the International Union of Biochemistry and Molecular Biology for work in epigenetics. [ + ]

Living Cell Technologies (ASX:LCT) has received an Australian patent for its encapsulation technology, while HealthLinx (ASX:HTX) had its OvPlex diagnostic technology patented in the UK. [ + ]

Professor Grau at the University of Sydney has been recognised with an award for developing a new method of studying cerebral malaria that avoids animal testing.